US Stock MarketDetailed Quotes

Cyclerion Therapeutics (CYCN)

Watchlist

3.130
-0.050-1.57%

Close May 13 15:59 ET

3.050
-0.080-2.56%

Post 20:01 ET

13.55MMarket Cap-2.39P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cyclerion Therapeutics (CYCN) Balance Sheet

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Assets

Current assets

Cash, cash equivalents and short term investments

0.25%3.24M

59.05%4.57M

-34.48%3.01M

-36.11%3.64M

-57.31%3.23M

-68.47%2.87M

-18.67%4.59M

-20.55%5.7M

-Cash and cash equivalents

0.25%3.24M

59.05%4.57M

-34.48%3.01M

-36.11%3.64M

-57.31%3.23M

-68.47%2.87M

-18.67%4.59M

-20.55%5.7M

Receivables

79.86%1M

127.27%100K

--525K

--581K

--556K

--44K

----

-Accounts receivable

79.86%1M

127.27%100K

--525K

--581K

--556K

--44K

----

Prepaid assets

-8.79%384K

-37.84%386K

298.28%462K

-16.88%256K

-4.75%421K

-14.46%621K

-88.89%116K

-45.68%308K

Other current assets

-31.25%11K

0.00%11K

145.45%27K

110.00%21K

45.45%16K

-63.33%11K

-97.43%11K

-98.01%10K

Total current assets

9.70%4.64M

42.76%5.07M

-14.74%4.02M

-25.22%4.5M

-47.35%4.23M

-64.03%3.55M

-33.71%4.72M

-27.85%6.01M

Non current assets

Net PPE

----

--0

----

--0

-Gross PPE

----

0.00%126K

----

-89.24%126K

-Accumulated depreciation

----

0.00%-126K

----

---126K

Investments and advances

0.00%5.35M

--5.35M

Total non current assets

0.00%5.35M

79.29%5.35M

71.42%5.35M

Total assets

4.28%9.99M

17.05%10.42M

-6.91%9.37M

-13.35%9.85M

-28.41%9.58M

-41.51%8.9M

-0.32%10.07M

-0.80%11.36M

Liabilities

Current liabilities

Payables

30.26%508K

57.89%480K

-29.03%462K

-34.82%483K

-67.45%390K

-62.65%304K

-65.08%651K

-81.12%741K

-accounts payable

30.26%508K

57.89%480K

-29.03%462K

-34.82%483K

-67.45%390K

-62.65%304K

-65.08%651K

-81.12%741K

Current accrued expenses

25.37%341K

-44.76%195K

-34.89%278K

0.00%539K

-64.90%272K

-66.44%353K

-82.02%427K

-80.59%539K

Other current liabilities

26.67%38K

137.21%102K

-70.59%60K

-72.05%45K

-73.45%30K

-72.78%43K

16.57%204K

15.00%161K

Current liabilities

24.14%900K

25.29%877K

-37.60%800K

-25.95%1.07M

-65.24%725K

-70.10%700K

-74.09%1.28M

-80.87%1.44M

Non current liabilities

Total non current liabilities

--0

Total liabilities

24.14%900K

25.29%877K

-37.60%800K

-25.95%1.07M

-65.24%725K

-70.10%700K

-74.09%1.28M

-80.87%1.44M

Shareholders'equity

Share capital

--0

-common stock

--0

-Preferred stock

--0

Retained earnings

-1.32%-271.02M

-0.82%-270.22M

-0.73%-269.25M

-1.11%-268.92M

-1.16%-267.49M

-2.02%-268.02M

1.11%-267.3M

0.06%-265.96M

Paid-in capital

1.36%280.11M

1.28%279.76M

0.63%277.82M

0.65%277.7M

0.23%276.34M

0.22%276.22M

0.23%276.08M

2.16%275.9M

Gains losses not affecting retained earnings

----

--0

15.79%-16K

Total stockholders'equity

2.66%9.09M

16.35%9.54M

-2.43%8.57M

-11.52%8.78M

-21.60%8.85M

-36.32%8.2M

70.54%8.78M

152.82%9.92M

Total equity

2.66%9.09M

16.35%9.54M

-2.43%8.57M

-11.52%8.78M

-21.60%8.85M

-36.32%8.2M

70.54%8.78M

152.82%9.92M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments	0.25%3.24M	0.25%3.24M	59.05%4.57M	-34.48%3.01M	-36.11%3.64M	-57.31%3.23M	-57.31%3.23M	-68.47%2.87M	-18.67%4.59M	-20.55%5.7M
-Cash and cash equivalents	0.25%3.24M	0.25%3.24M	59.05%4.57M	-34.48%3.01M	-36.11%3.64M	-57.31%3.23M	-57.31%3.23M	-68.47%2.87M	-18.67%4.59M	-20.55%5.7M
Receivables	79.86%1M	79.86%1M	127.27%100K	--525K	--581K	--556K	--556K	--44K	----	----
-Accounts receivable	79.86%1M	79.86%1M	127.27%100K	--525K	--581K	--556K	--556K	--44K	----	----
Prepaid assets	-8.79%384K	-8.79%384K	-37.84%386K	298.28%462K	-16.88%256K	-4.75%421K	-4.75%421K	-14.46%621K	-88.89%116K	-45.68%308K
Other current assets	-31.25%11K	-31.25%11K	0.00%11K	145.45%27K	110.00%21K	45.45%16K	45.45%16K	-63.33%11K	-97.43%11K	-98.01%10K
Total current assets	9.70%4.64M	9.70%4.64M	42.76%5.07M	-14.74%4.02M	-25.22%4.5M	-47.35%4.23M	-47.35%4.23M	-64.03%3.55M	-33.71%4.72M	-27.85%6.01M
Non current assets
Net PPE	----	----	----	----	----	--0	--0	----	----	--0
-Gross PPE	----	----	----	----	----	0.00%126K	0.00%126K	----	----	-89.24%126K
-Accumulated depreciation	----	----	----	----	----	0.00%-126K	0.00%-126K	----	----	---126K
Investments and advances	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	--5.35M	--5.35M
Total non current assets	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	79.29%5.35M	71.42%5.35M
Total assets	4.28%9.99M	4.28%9.99M	17.05%10.42M	-6.91%9.37M	-13.35%9.85M	-28.41%9.58M	-28.41%9.58M	-41.51%8.9M	-0.32%10.07M	-0.80%11.36M
Liabilities
Current liabilities
Payables	30.26%508K	30.26%508K	57.89%480K	-29.03%462K	-34.82%483K	-67.45%390K	-67.45%390K	-62.65%304K	-65.08%651K	-81.12%741K
-accounts payable	30.26%508K	30.26%508K	57.89%480K	-29.03%462K	-34.82%483K	-67.45%390K	-67.45%390K	-62.65%304K	-65.08%651K	-81.12%741K
Current accrued expenses	25.37%341K	25.37%341K	-44.76%195K	-34.89%278K	0.00%539K	-64.90%272K	-64.90%272K	-66.44%353K	-82.02%427K	-80.59%539K
Other current liabilities	26.67%38K	26.67%38K	137.21%102K	-70.59%60K	-72.05%45K	-73.45%30K	-73.45%30K	-72.78%43K	16.57%204K	15.00%161K
Current liabilities	24.14%900K	24.14%900K	25.29%877K	-37.60%800K	-25.95%1.07M	-65.24%725K	-65.24%725K	-70.10%700K	-74.09%1.28M	-80.87%1.44M
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	24.14%900K	24.14%900K	25.29%877K	-37.60%800K	-25.95%1.07M	-65.24%725K	-65.24%725K	-70.10%700K	-74.09%1.28M	-80.87%1.44M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-1.32%-271.02M	-1.32%-271.02M	-0.82%-270.22M	-0.73%-269.25M	-1.11%-268.92M	-1.16%-267.49M	-1.16%-267.49M	-2.02%-268.02M	1.11%-267.3M	0.06%-265.96M
Paid-in capital	1.36%280.11M	1.36%280.11M	1.28%279.76M	0.63%277.82M	0.65%277.7M	0.23%276.34M	0.23%276.34M	0.22%276.22M	0.23%276.08M	2.16%275.9M
Gains losses not affecting retained earnings	----	----	----	----	----	--0	--0	--0	--0	15.79%-16K
Total stockholders'equity	2.66%9.09M	2.66%9.09M	16.35%9.54M	-2.43%8.57M	-11.52%8.78M	-21.60%8.85M	-21.60%8.85M	-36.32%8.2M	70.54%8.78M	152.82%9.92M
Total equity	2.66%9.09M	2.66%9.09M	16.35%9.54M	-2.43%8.57M	-11.52%8.78M	-21.60%8.85M	-21.60%8.85M	-36.32%8.2M	70.54%8.78M	152.82%9.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm